Clinical Trial Update: Cofrogliptin and Linagliptin as add-on Therapy to Insulin in Type 2 Diabetes

View source ↗

Summary

A clinical trial evaluating cofrogliptin and linagliptin as add-on therapy to insulin in type 2 diabetes; recruitment is not yet underway.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Cofrogliptin (Cofrogliptin)
• Linagliptin (linagliptin)

Snippet

Sponsor: Yanbing Li | Conditions: Type 2 Diabetes | Status: NOT_YET_RECRUITING